Qol Holdings Co (TSE:3034) Debt-to-EBITDA : 2.50 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Qol Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円14,555 Mil. Qol Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円14,827 Mil. Qol Holdings Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円11,752 Mil. Qol Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Qol Holdings Co's Debt-to-EBITDA or its related term are showing as below:

TSE:3034' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.56 Med: 2.54 Max: 3.24
Current: 3.21

During the past 13 years, the highest Debt-to-EBITDA Ratio of Qol Holdings Co was 3.24. The lowest was 1.56. And the median was 2.54.

TSE:3034's Debt-to-EBITDA is ranked worse than
56.21% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs TSE:3034: 3.21

Qol Holdings Co Debt-to-EBITDA Historical Data

The historical data trend for Qol Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co Debt-to-EBITDA Chart

Qol Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-EBITDA

Get a 7-Day Free Trial

2.54

2.63

2.55

1.60

1.56

Qol Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															2.12	2.23	2.61	3.71	2.50

Competitive Comparison of Qol Holdings Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qol Holdings Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's Debt-to-EBITDA falls into.

Qol Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Qol Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(8712	+	14038)	/	14557
	=	1.56

Qol Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(14555	+	14827)	/	11752
	=	2.50

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Qol Holdings Co (TSE:3034) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Qol Holdings Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Qol Holdings Co (TSE:3034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452

Website

https://www.qolhd.co.jp

Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines